Facilitated By

San Antonio Medical Foundation

News

  • AstraZeneca buying drug developer Alexion for $39 billion

    ... Pfizer and Germany's BioNTech that has already earned some emergency approvals, and another by U.S. biotechnology company Moderna.

  • BioCryst bags $250M in a debt and royalty deal as the executive team preps a new drug launch for ...

    The biotech reported Monday morning that they've inked a deal with ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.

  • The Latest: Gov. Cuomo bans NYC indoor dining as cases climb

    BOSTON — A study published by the journal Science says as many as 300,000 COVID-19 cases around the world can be traced to a two-day biotech ...

  • Initial public offerings scheduled to debut next week

    Proposed Nasdaq symbol BCAB. Business: Phase 2 biotech developing selective antibody therapies for solid tumors. Dune Acquisition - West Palm ...

  • Middle Bit: Iowa Innovation Corporation rebrands to 'BioConnect Iowa'

    “Innovation in the biosciences offers a great opportunity for Iowa,” said Paul ... San Antonio, Texas-based financial startup FloatMe has raised a $3.7 ...